$51.90
-0.55 (-1.05%)
Analyst Consensus
Buy
32
Analysts
Very High
Coverage
Price Target
Analyst Price Target
+114.0% upside
Low Target
$83.97
Average Target
$111.08
High Target
$162.31
Current Price
$51.90
Current
$51.90
$51.90
Target
$111.08
$111.08
$83.97
$111.08 avg
$162.31
Scenario Analysis
Bear Case
$83.97
61.8%
Low target
Base Case
$111.08
+114.0%
Avg target
Bull Case
$162.31
+212.7%
High target
Risk/Reward
3.4x
Highly favorable
Price in Context
52-Week High
$78.48
-33.9% from high
52-Week Low
$44.12
+17.6% from low
50-Day SMA
$54.19
-4.2% vs SMA
200-Day SMA
$54.12
-4.1% vs SMA
RSI (14)
52.8
Neutral
Target vs 52W High
$111.08
+41.5% vs high
Next Earnings Report
Aug 10, 2026
2d
until earnings
EPS Est: $-1.23
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +5.0% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.2% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +171.2% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -9.5% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -42.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.3% |
| BIIB | Buy | 44 | 64% | $91.45 | -55.7% |